>AT4G30580.1 | ATS2 1-acylglycerol-3-phosphate O-acyltransferase/ acyltransferase
MDVASARSISSHPSYYGKPICSSQSSLIRISRDKVCCFGRISNGMTSFTTSLHAVPSEKF
MGETRRTGIQWSNRSLRHDPYRFLDKKSPRSSQLARDITVRADLSGAATPDSSFPEPEIK
LSSRLRGIFFCVVAGISATFLIVLMIIGHPFVLLFDPYRRKFHHFIAKLWASISIYPFYK
INIEGLENLPSSDTPAVYVSNHQSFLDIYTLLSLGKSFKFISKTGIFVIPIIGWAMSMMG
VVPLKRMDPRSQVDCLKRCMELLKKGASVFFFPEGTRSKDGRLGSFKKGAFTVAAKTGVA
VVPITLMGTGKIMPTGSEGILNHGNVRVIIHKPIHGSKADVLCNEARSKIAESMDL*
>AT2G25110.1 | SDF2 (STROMAL CELL-DERIVED FACTOR 2-LIKE PROTEIN PRECURSOR)
MALGFFCLAIFLYLSLDPDSGYTSASAAASGKEGVEITYGSAIKLMHEKTKFRLHSHDVP
YGSGSGQQSVTGFPGVVDSNSYWIVKPVPGTTEKQGDAVKSGATIRLQHMKTRKWLHSHL
HASPISGNLEVSCFGDDTNSDTGDHWKLIIEGSGKTWKQDQRVRLQHIDTSGYLHSHDKK
YQRIAGGQQEVCGIREKKADNIWLAAEGVYLPLNESSK*
>AT1G64790.1 | binding
MASPLESLLSISGSVSTSSTLIRLRIFRHDIPEILQNSDMTSDIAPVIVDMIFQTLAIYD
DRASRKAVDDLIVKGLGNVTFMKTFAAMLVQVMEKQLKFCFDTVCYRLLIWSCLLLEKSQ
FATVSKNAFVRVASTQASLLRIIMESSFRMRRACKRFMFHLFSQSQAIYSLYMDEVKGSR
IPYKDSPELLGLLLEFSCSSPALFEQSKAIFVDIYVKDVLNSREKQKPNLSNCFKPLLQR
LSHEEFQTVILPAAVKMLKRNPEIVLESVGFLLANVNIDLSKYALELLPVILPQARHTDE
DRRLGALSMVMCLSEKSSNPDTIEAMFASVKAIIGGSEGRLQSPHQRIGMLNAVQELASA
PEGKYIGSLSRTICSFLIACYKDEGNEDVKLSILSAVASWASRSSVAIQPNLVSFIAAGL
KEKEALRRGHLRCVRIICRNPDTISQISDLLSPLIQLVKTGFTKAVQRLDGIYALLIVSK
IAACDIKAEDTMVKEKLWTLISQNEPSLVQITLASKLSSDDCVVCVDLLEVLLVEHSSRV
LEAFSLKSLSQLLLFLLCHPSWNVRKTAYNSVTKIFLATSQLATTLLDEFSDFLSITGDQ
IVSSRTSDADNPADHQAPFVPSVEVLVKALIVISSAAVAGPPSSWIVRAIFCSHHPSIVG
TGKRDAVWKRLQKCLKTCGFDVATFLSTNGESVCKSLLGPMGLTSAKTPEQQAAVYSLST
MMSLAPEDTFTVFKMHLQDLPDRLSHDMLSETDIKIFHTPEGMLLSEQGVYVAQTIGAKY
TKQEPSSNHSLKKGLASRETANSGRRDTAKLTKKADKGKTAKEEARELMLKEEASTRENV
HRIQKSLSLVLHALGEMGLANPVFCHSQLPFLATFLDPLLRSPIVSAAAFENLVKLARCT
VQPLCNWALEISTALRLIAIDEVDTSFDFRPSVDKAGKTYEGLFERIVNGLSISCKSGPL
PVDTFTFIFPILERILLSSKRTKLHDDVLQILYMHLDPMLPLPRLRMISVLYHVLGVVPA
YQASVGPALNELCLGLQADDVANALYGVYSKDVHVRLACLNAVKCIPAVSKCSLPQNVKI
ATNIWIALHDPEKSVAESADDLWARYGHDLGTDYSGIFKALSHINLNVRLAAAEALADAL
HESPSSIQLSLSTLFSLYIRDATSGEDVFDAGWIGRQGIALALQSAADVLTTKDLPAVMT
FLISRALADPNTDVRGKMINAGIMIIDKHGKENVSLLFPIFENYLNKEASDEEEYDLVRE
GVVIFTGALAKHLARDDPKVHNVVEKLLEVLNTPSESVQRAVSTCLSPLVLSKQEEAPAL
FLRLLDKLMKSDKYGERRGAAFGLAGVVMGFGISSLKKYGLIVTLQEALIDRNSAKRREG
ALLAFECLCEKLGKLFEPYVIKMLPLLLVSFSDQVGAVREAAECAARAMMSQLSAYGVKL
VLPSLLKGLEDKAWRTKQSSVQLLGAMAFCAPQQLSQCLPRVVPKLTEVLTDTHPKVQSA
GQLALQQVGSVIKNPEISSLVPTLLLALTDPNEYTRHALDTLLQTTFVNSVDAPSLALLV
PIVHRGLRERSSETKKKASQIVGNMCSLVTEPKDMIPYIGLLLPEVKKVLVDPIPEVRSV
AARAVGSLIRGMGEDNFPDLVPWLFETLKSDTSNVERYGAAQGLSEVIAALGTDYFENIL
PDLIRHCSHQKASVRDGYLTLFKFLPRSLGAQFQKYLQLVLPAILDGLADENESVRDAAL
GAGHVLVEHHATTSLPLLLPAVEDGIFNDNWRIRQSSVELLGDLLFKVAGTSGKALLEGG
SDDEGASTEAQGRAIIDILGMDKRNEVLAALYMVRTDVSLSVRQAALHVWKTIVANTPKT
LKEIMPILMSTLISSLASPSSERRQVAGRSLGELVRKLGERVLPLIIPILSKGLKDPDVD
KRQGVCIGLNEVMASAGRSQLLSFMDQLIPTIRTALCDSALEVRESAGLAFSTLYKSAGL
QAMDEIIPTLLEALEDDEMSTTALDGLKQIISVRTAAVLPHILPKLVHLPLSALNAHALG
ALAEVAGAGFNTHLGTILPALLSAMGGENKEVQELAQEAAERVVLVIDEEGVETLLSELL
KGVSDSQASIRRSSAYLIGYFFKSSKLYLIDEAPNMISTLIVMLSDSDSTTVAVSWEALA
RVIGSVPKEVLPSYIKLVRDAVSTARDKERRKRKGGYVVIPGLCLPKSLKPLLPVFLQGL
ISGSAELREQAAIGLGELIEVTSEQALKEFVIPITGPLIRIIGDRFPWQVKSAILATLII
LIQRGGMALKPFLPQLQTTFVKCLQDSTRTIRSSAAVALGKLSALSTRIDPLVGDLMTSF
QAADSGVREAILSAMRGVIKHAGKSIGPAVRVRIFDLLKDLMHHEDDQVRISATSMLGVL
SQYLEAAQLSVLLQEVNDLSASQNWGARHGSVLCISSLLKHNPSTIMTSSLFSSMLNSLK
SSLKDEKFPLRESSTKALGRLLLKQLATDPSNTKVVIDVLSSIVSALHDDSSEVRRRALS
SLKAFAKDNPSATMANISVIGPPLAECLKDGNTPVRLAAERCALHVFQLTKGAENVQAAQ
KYITGLDARRLSKFPEQSDDSESDDDNVSG*
>AT3G18190.1 | chaperonin putative
MAAVAAPMASKPRGSKAESFVDNKRREDIRFANINSARAVSDAVRTSLGPKGMDKMISTA
NGEVIITNDGATILNKMEVLQPAAKMLVELSKSQDSAAGDGTTTVVVIAGALLKECQSLL
TNGIHPTVISDSLHKACGKAIDILTAMAVPVELTDRDSLVKSASTSLNSKVVSQYSTLLA
PLAVDAVLSVIDPEKPEIVDLRDIKIVKKLGGTVDDTHTVKGLVFDKKVSRAAGGPTRVE
NAKIAVIQFQISPPKTDIEQSIVVSDYTQMDRILKEERNYILGMIKKIKATGCNVLLIQK
SILRDAVTDLSLHYLAKAKIMVIKDVERDEIEFVTKTLNCLPIANIEHFRAEKLGHADLV
EEASLGDGKILKITGIKDMGRTTSVLVRGSNQLVLDEAERSLHDALCVVRCLVSKRFLIA
GGGAPEIELSRQLGAWAKVLHGMEGYCVKSFAEALEVIPYTLAENAGLNPIAIVTELRNK
HAQGEINAGINVRKGQITNILEENVVQPLLVSTSAITLATECVRMILKIDDIVTVR*
>AT1G12640.1 | membrane bound O-acyl transferase (MBOAT) family protein
MDMSSMAGSIGVSVAVLRFLLCFVATIPVSFACRIVPSRLGKHLYAAASGAFLSYLSFGF
SSNLHFLVPMTIGYASMAIYRPKCGIITFFLGFAYLIGCHVFYMSGDAWKEGGIDSTGAL
MVLTLKVISCSMNYNDGMLKEEGLREAQKKNRLIQMPSLIEYFGYCLCCGSHFAGPVYEM
KDYLEWTEGKGIWDTTEKRKKPSPYGATIRAILQAAICMALYLYLVPQYPLTRFTEPVYQ
EWGFLRKFSYQYMAGFTARWKYYFIWSISEASIIISGLGFSGWTDDASPKPKWDRAKNVD
ILGVELAKSAVQIPLVWNIQVSTWLRHYVYERLVQNGKKAGFFQLLATQTVSAVWHGLYP
GYMMFFVQSALMIAGSRVIYRWQQAISPKMAMLRNIMVFINFLYTVLVLNYSAVGFMVLS
LHETLTAYGSVYYIGTIIPVGLILLSYVVPAKPSRPKPRKEE*
>AT4G36480.1 | ATLCB1 (LONG-CHAIN BASE1) protein binding / serine C-palmitoyltransferase
MASNLVEMFNAALNWVTMILESPSARVVLFGVPIRGHFFVEGLLGVVIIILLTRKSYKPP
KRPLTEQEIDELCDEWVPEPLIPPITEDMKHEPPVLESAAGPHTTVNGKDVVNFASANYL
GLIGHEKLLESCTSALEKYGVGSCGPRGFYGTIDVHLDCETRISKFLGTPDSILYSYGLS
TMFSTIPCFCKKGDVIVADEGVHWGIQNGLQLSRSTIVYFKHNDMESLRITLEKIMTKYK
RSKNLRRYIVAEAVYQNSGQIAPLDEIVKLKEKYRFRVILDESNSFGVLGRSGRGLAEHH
SVPIEKIDVVTAAMGHALATEGGFCTGNARIIDYQRLSSSGYVFSASLPPYLASAAITAI
DVIDQNPDMLVKLKQNVALLWKGLSDIKGMSLTSNRESPIVFLKLEKSSGSAKDDLLLLE
KMADRALKEDSLLVVSSKRSFLDKCRLPVGIKLYVSAGHSESDLLKASESLKRLASELLL
KS*
>AT4G36480.1 | ATLCB1 (LONG-CHAIN BASE1) protein binding / serine C-palmitoyltransferase
MASNLVEMFNAALNWVTMILESPSARVVLFGVPIRGHFFVEGLLGVVIIILLTRKSYKPP
KRPLTEQEIDELCDEWVPEPLIPPITEDMKHEPPVLESAAGPHTTVNGKDVVNFASANYL
GLIGHEKLLESCTSALEKYGVGSCGPRGFYGTIDVHLDCETRISKFLGTPDSILYSYGLS
TMFSTIPCFCKKGDVIVADEGVHWGIQNGLQLSRSTIVYFKHNDMESLRITLEKIMTKYK
RSKNLRRYIVAEAVYQNSGQIAPLDEIVKLKEKYRFRVILDESNSFGVLGRSGRGLAEHH
SVPIEKIDVVTAAMGHALATEGGFCTGNARIIDYQRLSSSGYVFSASLPPYLASAAITAI
DVIDQNPDMLVKLKQNVALLWKGLSDIKGMSLTSNRESPIVFLKLEKSSGSAKDDLLLLE
KMADRALKEDSLLVVSSKRSFLDKCRLPVGIKLYVSAGHSESDLLKASESLKRLASELLL
KS*
>AT4G36480.2 | ATLCB1 (LONG-CHAIN BASE1) protein binding / serine C-palmitoyltransferase
MASNLVEMFNAALNWVTMILESPSARVVLFGVPIRGHFFVEGLLGVVIIILLTRKSYKPP
KRPLTEQEIDELCDEWVPEPLIPPITEDMKHEPPVLESAAGPHTTVNGKDVVNFASANYL
GLIGHEKLLESCTSALEKYGVGSCGPRGFYGTIDVHLDCETRISKFLGTPDSILYSYGLS
TMFSTIPCFCKKGDVIVADEGVHWGIQNGLQLSRSTIVYFKHNDMESLRITLEKIMTKYK
RSKNLRRYIVAEAVYQNSGQIAPLDEIVKLKEKYRFRVILDESNSFGVLGRSGRGLAEHH
SVPIEKIDVVTAAMGHALATEGGFCTGNARIIDYQRLSSSGYVFSASLPPYLASAAITAI
DVIDQNPDMLVKLKQNVALLWKGLSDIKGMSLTSNRESPIVFLKLEKSSGSAKDDLLLLE
KMADRALKEDSLLVVSSKRSFLDKCRLPVGIKLYVSAGHSESDLLKASESLKRLASELLL
KS*
>AT4G36480.2 | ATLCB1 (LONG-CHAIN BASE1) protein binding / serine C-palmitoyltransferase
MASNLVEMFNAALNWVTMILESPSARVVLFGVPIRGHFFVEGLLGVVIIILLTRKSYKPP
KRPLTEQEIDELCDEWVPEPLIPPITEDMKHEPPVLESAAGPHTTVNGKDVVNFASANYL
GLIGHEKLLESCTSALEKYGVGSCGPRGFYGTIDVHLDCETRISKFLGTPDSILYSYGLS
TMFSTIPCFCKKGDVIVADEGVHWGIQNGLQLSRSTIVYFKHNDMESLRITLEKIMTKYK
RSKNLRRYIVAEAVYQNSGQIAPLDEIVKLKEKYRFRVILDESNSFGVLGRSGRGLAEHH
SVPIEKIDVVTAAMGHALATEGGFCTGNARIIDYQRLSSSGYVFSASLPPYLASAAITAI
DVIDQNPDMLVKLKQNVALLWKGLSDIKGMSLTSNRESPIVFLKLEKSSGSAKDDLLLLE
KMADRALKEDSLLVVSSKRSFLDKCRLPVGIKLYVSAGHSESDLLKASESLKRLASELLL
KS*
>AT1G58050.1 | helicase domain-containing protein
MAPTKKPQKNKQSKNEIASSLIPNSGHKKPSKAPKLLISPENEDRLRRLLLNFRRTPSPV
TATLSVTQKRKKLNNLYENLSCEGFLDNQIELVLSSLRDGATLETALDWLCLNLPSHELP
VNFSNGASRFPSTGRSVAVISKSKKDWNVSAESSVQEVKEVPESEVLVRVKSKRDEEEED
SLSSCQPSQADWIHQYMKRLEEEELESSDDERDKVSGPRSFEVIAKEYCVERYNAIKAKR
KGDKSGQSQAGLAICKLKEEMNALGPSEAILESEFQRDRQDCEGAREKEVASSVLDDVHE
SVNADAFFFQLFDDLTLDTNPVGSCKSEEQESVVSNDSLDDLDLGDLFDEDVPPYVPSPH
ELLELQKKEIMRELCNEKHLTKLNGIWKKGEAQKIPKALLHQLCQRSGWIAPKFNKVTGE
GRNFSYTTSVMRKSSGFGKSRQAGGLVTIQLPHQVEDFESIQDAQNRVAAFALHKLFSDL
PVHFAITEPYASLVLIWKQEESLGITSREEQRREKFVESLLEADNFSLTTTSRGIHSALP
MVDSCVKENDDLDVVKSNHRARRNSSMAAECSSLKQKQENKKKMQKYKDMLKTRAALPIS
EVKKDILQKLKEKDVLVVCGETGSGKTTQVPQFILDDMIDSGHGGYCNIICTQPRAITVA
QRVADERCEPPPGFDNSVVAYQVRHQNARSDKTRLLFCTTGILLRKLVGDTTLKDVTHII
VDEVHERSLMGDFLLIILKSLIEKQSWDNALPKLKVILMSATVDAHQFSRYFGQCPIITA
QGRTHPVTTYFLEDIYERTKYLLASDSPAALSSDTSITDKLGSVNVPRGKKNLMLAGWGD
SYLVSEDSLNTSYDSIKYIASAVVDYDLLEELICHIDDTCEEGAILVFLPGMSEINMLLN
RLAASYRFRGASGDWLLPLHSSIASTEQKKVFLRPPKGIRKVIIATNIAETSITIEDVVY
VIDSGKHKENRYNPHKKLSSMVEDWVSKANARQRMGRAGRVKPGHCFSLYTRHRFEKLMR
PYQVPEMLRVPLVELCLHIKLLGLGQIKPFLSKALEPPSESAINSAILLLHKVGALEGDE
ELTPLGHHLAKLPVDLLIGKMLLYGGIFGCLSPILSIAAFLSCCKSPFVYAKDEQNVDRV
KLALLSDKLESSSNLNNNDRQSDHLLMVVAYEKWVRILHEQGFKAAESFCESKFLNSSVM
RMMRERRVEFGMLLADIGLINLPKGKGRRKENFDVWFSDKTQPFNMYSQEPEVVKAILCA
GLCPNIAEGLVNRLTKPAEETQRYAVWHDGKREVHIHRNSINKNCKAFQYPFIVFLEKLE
TKKVVYLQDTTVVSPFSILLFGGSINVHHQSGSVTIDGWLKLTAPAQTAVLFKELRLTLH
SILKDLIRKPEKSGIVHNEVVKSMVHLLIEEGKPQHT*
>AT1G64550.1 | ATGCN3 transporter
MTEVASSVVYEVLGRRAQDVDEPIMDYIINVLADEDFDFGEEGEGAFDAVGELLVAAECV
SDFEECRLVCSKLSDKFGKHGLVKPTPTVRSLAMPVRMNDGMDDGPVKKKKPEPVDGPLL
TERDLAKIERRKKKDDRQRELQYQQHVAEMEAAKAGMPTVSVNHDTGGGSAIRDIHMDNF
NVSVGGRDLIVDGSITLSFGRHYGLVGRNGTGKTTFLRYMAMHAIEGIPTNCQILHVEQE
VVGDKTTALQCVLNTDIERTKLLEEEIQILAKQRETEEPTAKDGMPTKDTVEGDLMSQRL
EEIYKRLDAIDAYTAEARAASILAGLSFTPEMQLKATNTFSGGWRMRIALARALFIEPDL
LLLDEPTNHLDLHAVLWLETYLTKWPKTFIVVSHAREFLNTVVTDIIHLQNQKLSTYKGN
YDIFERTREEQVKNQQKAFESSERSRSHMQAFIDKFRYNAKRASLVQSRIKALDRLAHVD
QVINDPDYKFEFPTPDDKPGPPIISFSDASFGYPGGPLLFRNLNFGIDLDSRIAMVGPNG
IGKSTILKLISGDLQPSSGTVFRSAKVRVAVFSQHHVDGLDLSSNPLLYMMRCYPGVPEQ
KLRSHLGSLGVTGNLALQPMYTLSGGQKSRVAFAKITFKKPHLLLLDEPSNHLDLDAVEA
LIQGLVLFQGGICMVSHDEHLISGSVDELWVVSDGRIAPFHGTFHDYKKLLQSST*
>AT3G06460.1 | GNS1/SUR4 membrane family protein
MASVYSTLTYWLVHHPYIANFTWTEGETLGSTVFFVFVVVSLYLSATFLLRYTVDSLPTL
GPRILKPITAVHSLILFLLSLTMAVGCTLSLISSSDPKARLFDAVCFPLDVKPKGPLFFW
AQVFYLSKILEFVDTLLIILNKSIQRLSFLHVYHHATVVILCYLWLRTRQSMFPVGLVLN
STVHVIMYGYYFLCAIGSRPKWKKLVTNFQMVQFAFGMGLGAAWMLPEHYFGSGCAGIWT
VYFNGVFTASLLALFYNFHSKNYEKTTTSPLYKIESFIFIHGERWANKAITLFSKKND*
>AT3G60860.1 | guanine nucleotide exchange family protein
MASSEADSRLSRVVTPALEKIVKNASWRKHSKLANECKAVIERLNSLQKSPPPSSSAATD
SESESSVPGPLNDGGSIEYSLADSELIFSPLINACGTGLAKIIEPAIDCIQKLIAHGYIR
GESDPSGGAESLLLFKLIDSVCKCHDLGDESIELPVLKTLLSAINSISLRIHGKCLLLVV
RTCYDIYLGSKNVVNQTTAKASLIQILVIVFRRMEADSSTVPIQPIVVAELMEPLEKSDA
DGTMTQFVQGFITKIMQDIDGVLNPTMSGSGSGSGSGGQDGAYGTTTVETTNPTDLLDST
DKDMLDAKYWEISMYKSALEGRKGELTDGDAERDDDLEVQIENKLRRDACLVFRALCKLS
MKAPPKESSADPQSMRGKILALELLKILLENAGAVFRTSEKFSADIKQFLCLSLLKNSAS
TLMIIFQLSCSIFISLVARFRAGLKAEIGVFFPMIVLRVVENVAQPNFQQKMIVLRFLDK
LCLDSQILVDIFLNYDCDVNSSNIFERMVNGLLKTAQGVPPGTATTLMPPQEAAMKLEAM
KCLVAILKSMGDWLNKQLRLPVSNSLNKSDVIEIDLGPGSPQLANGNADESADGSDTYSE
SSGGTSDALAIEQRRAYKLELQEGISLFNRKPTKGIEFLINAGKVGESPEEIAGFLKDAS
GLNKTLIGDYLGEREDLALKVMHAYVDSFDFRGMEFDEAIRTFLEGFRLPGEAQKIDRIM
EKFAERYCKCNPKVFTSADSAYVLAYSVIMLNTDAHNPMVKNKMSADDFIRNNRGIDDGK
DLPADYMRSLYERITKHEIKMKEDDLRLQQKQYANSNRMLGLDGILNIVIRKQWGDSYAE
TSDDLMKHMQEQFKEKARKSESTYYAATDVVILRFMIEACWAPMLAAFSVPLDQSDDLIV
INICLEGFHHAIHATSLMSMKTHRDAFVTSLAKFTSLHSPADIKQRNIEAIKAILRLADE
EGNYLQDAWEHILTCVSRFEQLHLLGEGAPPDATFFASKQNESEKSKQPKQYILPVLKRK
GPGKSQYAATGVLRGSYDSMSLGGKGSKNVRQEQMSSIVSNLNLLEQVGEMNQVFSQSQK
LNSEAIIDFVKALCKVSMDELRSPSNPRVFSLTKIVEIAHYNMNRIRLVWSSIWQVLSGF
FVTIGCSENLSIAIFAMDSLRQLSMKFLEREELANYNFQNEFMTPFVIVMRRSNDVEIRE
LIIRCVSQMVLSRVNNVKSGWKSMFMVFTTAAYDDHKNIVFLSFEIIEKIIREYFPYITE
TETTTFTDCVNCLVAFTNNRFSKDISLSSIAFLRYCATKLAEGDLNSPSTNKYKGTSGKI
PQSSLHSGKSGKQENGEIVNNNHLYFWFPLLSGLSELSFDPRPEIRKSALQIMFDTLRNH
GHLFSLPLWEKVFESVLFPIFDYVRHSIDPSGEDESADQGSSGGEVDELDHDAWLYETCT
LALQLVVDLFVKFYTTVNPLLEKVLMLLVSFIKRPHQSLAGIGIAAFVRLMSDADGLFSE
EKWLEVVSALKEAAKTTCPDFSYFLSEEYVARSQRSALNIQNSNAESAAPTATDGNEESQ
RTATHLYAAISDAKCRAAVQLLLIQAVMEIYNMYRPQLSAKNTLVLVDALHGVALHAHGI
NSNTILRSRLQELGPMTQMQDPPLLRLENESYQICLTFLQNLVADKTKKEEEEEEEEIES
LLVNICQEVLNFYIETSSSAKKLQSESSRASEYRWRIPLGSGKRRELSARAPLIVATLQA
MCTLDEASFEKNLKCLFPLLANLISCEHGSNEVQTALADMLGLSVGPVLLQWC*
>AT4G22540.2 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.2 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.2 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.1 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MRVKELHPLCCITLESPHGINSQSPEEPVTTALTRSRSLPAKSLTGGSESETVAGILYKW
TNFGKGWRSRWFLLRNGILSYSKIRRPENLNLLSPDDDVRLIGDISGERLSRMDSCSGRR
KQQKTVGIVHLKVSSFRESKSDDRKFYIFTATKTLHLRTDSITDRAAWLQALASTKCIFP
LRSLNGDFSFIPPKDLSISTERLKKRLHEEGMNENLVKECEQIMLSEFSEMHGQVKLLHE
ERTNLLDALRQLEAANLEVGASGKHEFSSLGRGKYSECSTTASSDGKQEFEDVSEEDEPS
FHDTKEFFNEPNIGSESNLAISGHTDIKRRTKLPDPAEKEKGVSLWSMIKDNVGKDLTRV
CLPVYFNEPISSLQKCFEDLEYSYLLDRAYEHGKSGNGLLRALNVAAFAVSGYASTEGRH
CKPFNPLLGETYEADFPEKGIRFFSEKVSHHPTVIACHCEGKGWKFWGDTNLRSKFWGRS
IQVEPVGVLTLEFDDGEVFQWSKVTSTIYNIILGKLYCDHHGVMQIRGNRQYSCTLKFKE
QSILERNPHQVNGFVEDVAGQKAATIFGKWDDSLYYVAGDGINKSKVSDPASNASLLWKR
TKPPPNVTRYNLTSFAITLNELTPGLQEILPPTDSRLRPDQRHLENGEYEKANLEKQRLE
RRQRMSRQLQESGWRPRWFERQGESDTFKYTGGYWEARGHRNWDDCPDIFGEFTEELADA
A*
>AT4G22540.1 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MRVKELHPLCCITLESPHGINSQSPEEPVTTALTRSRSLPAKSLTGGSESETVAGILYKW
TNFGKGWRSRWFLLRNGILSYSKIRRPENLNLLSPDDDVRLIGDISGERLSRMDSCSGRR
KQQKTVGIVHLKVSSFRESKSDDRKFYIFTATKTLHLRTDSITDRAAWLQALASTKCIFP
LRSLNGDFSFIPPKDLSISTERLKKRLHEEGMNENLVKECEQIMLSEFSEMHGQVKLLHE
ERTNLLDALRQLEAANLEVGASGKHEFSSLGRGKYSECSTTASSDGKQEFEDVSEEDEPS
FHDTKEFFNEPNIGSESNLAISGHTDIKRRTKLPDPAEKEKGVSLWSMIKDNVGKDLTRV
CLPVYFNEPISSLQKCFEDLEYSYLLDRAYEHGKSGNGLLRALNVAAFAVSGYASTEGRH
CKPFNPLLGETYEADFPEKGIRFFSEKVSHHPTVIACHCEGKGWKFWGDTNLRSKFWGRS
IQVEPVGVLTLEFDDGEVFQWSKVTSTIYNIILGKLYCDHHGVMQIRGNRQYSCTLKFKE
QSILERNPHQVNGFVEDVAGQKAATIFGKWDDSLYYVAGDGINKSKVSDPASNASLLWKR
TKPPPNVTRYNLTSFAITLNELTPGLQEILPPTDSRLRPDQRHLENGEYEKANLEKQRLE
RRQRMSRQLQESGWRPRWFERQGESDTFKYTGGYWEARGHRNWDDCPDIFGEFTEELADA
A*
>AT4G22540.1 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MRVKELHPLCCITLESPHGINSQSPEEPVTTALTRSRSLPAKSLTGGSESETVAGILYKW
TNFGKGWRSRWFLLRNGILSYSKIRRPENLNLLSPDDDVRLIGDISGERLSRMDSCSGRR
KQQKTVGIVHLKVSSFRESKSDDRKFYIFTATKTLHLRTDSITDRAAWLQALASTKCIFP
LRSLNGDFSFIPPKDLSISTERLKKRLHEEGMNENLVKECEQIMLSEFSEMHGQVKLLHE
ERTNLLDALRQLEAANLEVGASGKHEFSSLGRGKYSECSTTASSDGKQEFEDVSEEDEPS
FHDTKEFFNEPNIGSESNLAISGHTDIKRRTKLPDPAEKEKGVSLWSMIKDNVGKDLTRV
CLPVYFNEPISSLQKCFEDLEYSYLLDRAYEHGKSGNGLLRALNVAAFAVSGYASTEGRH
CKPFNPLLGETYEADFPEKGIRFFSEKVSHHPTVIACHCEGKGWKFWGDTNLRSKFWGRS
IQVEPVGVLTLEFDDGEVFQWSKVTSTIYNIILGKLYCDHHGVMQIRGNRQYSCTLKFKE
QSILERNPHQVNGFVEDVAGQKAATIFGKWDDSLYYVAGDGINKSKVSDPASNASLLWKR
TKPPPNVTRYNLTSFAITLNELTPGLQEILPPTDSRLRPDQRHLENGEYEKANLEKQRLE
RRQRMSRQLQESGWRPRWFERQGESDTFKYTGGYWEARGHRNWDDCPDIFGEFTEELADA
A*
>AT4G22540.3 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.3 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.3 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G27640.1 | importin beta-2 subunit family protein
MAQSLELLLIQFLMPDNDARRQAEDQIKRLAKDPQVVPALVQHLRTAKTPNVRQLAAVLL
RKRITGHWAKLSPQLKQHVKQSLIESITVENSPPVRRASANVVSVVAKYAVPAGEWPDLL
TFLFQCSQSAQEDHREVALILFSSLTETIGNTFRPYFADLQALLLKCMQDESSSRVRVAA
LKAVGSFLEFTNDGDEVVKFRDFIPSILDVSRKCIASGEEDVAILAFEIFDELIESPAPL
LGDSVKAIVQFSLEVSCNQNLESSTRHQAIQIVSWLAKYKYNSLKKHKLVIPILQVMCPL
LAESSDQEDDDDLAPDRASAEVIDTLAMNLPKHVFLPVLEFASVHCQSTNLKFREASVTA
LGVISEGCFDLMKEKLDTVLNIVLGALRDPELVVRGAASFAIGQFAEHLQPEILSHYQSV
LPCLLIAIEDTSEEVKEKSHYALAAFCENMGEEIVPLLDHLMGKLMAALENSPRNLQETC
MSAIGSVAAAAEQAFNPYAERVLELMKFFMVLTKDEDLRARARSTELVGIVAMSVGRKGM
EAILPPFIDAAISGFELEFSELREYTHGFFSNVAEILDDTFAQYLPRVMPLVFASCNLDD
GSAVDIDESDDENVNDFGGVSSDDDADDEPRVRNISVRTGVLDEKAAATQALGLFALHTK
SAFAPYLEESLKIMDKHSAYFHEDVRLQAVTGLKHILAAAHAIFQTHNDGTGKANEILDT
VMNNYIKTMTDDDDKEVVAQACISVADIMKDYGYPAIQKYLSPLVDATLLLLTEKAACQQ
LEDESDIDDDDTGHDEVLMDAVSDLLPAFAKCMGSQFEPVFAQFFEPLMKFAKASRPPQD
RTMVVASLAEVAQDMGLPISSYVDRLMPLVLKELGSPEATNRRNAAFCVGELCKNGGETA
LKYFGDVLRGISPLFGDSEPDLAVRDNAAGATARMIVVHPQLVPLNQVLPVFLRGLPLKE
DQEESMAVYTCIYSLVSSSNPQIFSHVPELVKIFGQVLESPVEKVEVKAIVGRTFSHLIS
VYGNQLQPIISSLPPSQANVLAAFASTS*
>AT1G53880.1 | GTP binding / translation initiation factor
MVKIHPDKAFPVDFSVGEGKTSPYLTTEKESFTIWMRSLVFHSKGCTVFDSKGNLIYRVD
NYNSKSCSEVYLMDLYGKILFTLRQKKLGLFKSWKGYNSTGTRFQLRKNFKILPKGSSSS
YKVVMGSRIVDGDHQSCYKIVKRKSVFTIEDGSGRLLAEVKKKQSNIKSLDLGKDVLTMM
VEPQLETEIFEEFIKMWRESASFILDKHQNNKPISLTHSIDSPPPPSASMADENPNPNPI
SAYYQTRAAHHGIVTSEWLEQAQAAVRRYPDRDSLVSGRPFSVIEDFNSWRQQPDLAEAV
AAIRALAAVIRASEATTMMELEIELKKASDTLKSWDTTSISLTAGCDLFMRYVTRTSALE
FEDFNSAKSRVLERAEKFGEISCKARTIIAMLSQDFIFDGCTILVHGFSRVVFEILKTSA
QNKKLFRVLCTEGRPDKTGVLLANELAKLDIPVKLLIDSAVAYSMDEVDMVFVGADGVVE
SGGIINMMGTYQIALVAQSMNKPVYVAAESYKFARLYPLDQKDLEPALRPIDFSVPVPPK
VEVERSARDYTPPQYLTLLFTDLGVLTPSVVSDELIQLYL*
>AT5G42000.1 | ORMDL family protein
MYVRALPTTDVNRNTEWFTYPGVWTTYILILFFSWLLVLSVFHCSPGIAWTIVHLAHFTV
TYHSFHWKKGTPFGDDQGVYNRLTWWEQIDNGKQLTRNRKFLTVVPVVLYLIASHTTDYQ
HPMLFLNTLAVFVMVVAKFPHMHKVRIFGINGDQ*
>AT5G42000.1 | ORMDL family protein
MYVRALPTTDVNRNTEWFTYPGVWTTYILILFFSWLLVLSVFHCSPGIAWTIVHLAHFTV
TYHSFHWKKGTPFGDDQGVYNRLTWWEQIDNGKQLTRNRKFLTVVPVVLYLIASHTTDYQ
HPMLFLNTLAVFVMVVAKFPHMHKVRIFGINGDQ*
>AT5G42000.2 | ORMDL family protein
MYVRALPTTDVNRNTEWFTYPGVWTTYILILFFSWLLVLSVFHCSPGIAWTIVHLAHFTV
TYHSFHWKKGTPFGDDQGVYNRLTWWEQIDNGKQLTRNRKFLTVVPVVL*
>AT5G42000.2 | ORMDL family protein
MYVRALPTTDVNRNTEWFTYPGVWTTYILILFFSWLLVLSVFHCSPGIAWTIVHLAHFTV
TYHSFHWKKGTPFGDDQGVYNRLTWWEQIDNGKQLTRNRKFLTVVPVVL*
>AT4G34490.1 | ATCAP1 (ARABIDOPSIS THALIANA CYCLASE ASSOCIATED PROTEIN 1) actin binding
MEEDLIKRLEAAVTRLEGISSNGGGVVSLSRGGDFSSAAGIDIASSDPSILAYEDLISQC
VGRALTAAEKIGGPVLDVTKIVAEAFASQKELLVRIKQTQKPDLAGLAGFLKPLNDVTMK
ANAMTEGKRSDFFNHLKAACDSLSALAWIAFTGKDCGMSMPIAHVEESWQMAEFYNNKVL
VEYRNKDADHVEWAKALKELYLPGLREYVKSHYPLGPVWNASGKPASAPAKGPPGAPAPP
PAPLFSAESSKPSSSSNQKQGMSAVFQQLSSGAVTSGLRKVTDDMKTKNRADRSGAVSAV
EKETRTSKPAFSKTGPPKMELQMGRKWAVENQIGKKDLVISECDSKQSVYIYGCKDSVLQ
IQGKVNNITIDKCTKVGVVFTDVVAAFEIVNCNNVEVQCQGSAPTVSVDNTTGCQLYLNK
DSLETAITTAKSSEINVMVPGATPDGDWVEHALPQQYNHVFTEGKFETTPVSHSGA*